Funded Research
Since 2003, Cancer Council ACT has contributed over $2,200,000 to local cancer research.
Normalising the tumour microenvironment to improve treatment outcomes for triple negative breast cancer.
Dr Teresa Bonelo, 2024-25, $75,000
Developing novel therapies for EZH2 driven B-cell lymphoma.
Dr Rachel Woodhouse, 2024-25, $75,000
Understanding how FUBP1 drives primary brain cancer towards rational drug discovery.
Dr Olga Zaytseva, 2022-23, $75,000
Testing GSTO1 inhibitors as anti-cancer therapeutics.
Emeritus Professor Philip Board, 2022-23, $75,000
How does sensing of DNA and DNA damage contribute to the development of colorectal cancer?
Dr Anukriti Mathur, 2021-22, $65,000
Evaluating the potential of combinatorial therapy with RNA polymerase I inhibitors to counteract chemotherapy-induced thrombocytopenia.
Dr Rita Ferreira, 2021-22, $65,000
Epigenetic regulator H2A.B as a novel target for treatment of Hodgkin Lymphoma.
Dr Tatiana Soboleva, 2020-21, $61,265
The nucleolar stress response at the centre of the malignant phenotype.
Dr Anne Steins, 2020-21, $64,985
Investigating the role of MYB in Burkitt lymphoma.
Dr Keisuke Horikawa, 2019-20, $65,000
Targeting cancer metabolism to reduce metastases.
A/Prof Anneke Blackburn, 2018-19, $65,000
Mechanisms and targets of protein synthesis dysregulation in cancer.
Prof Thomas Preiss, 2016-2019, $600,000
How exercise prevents obesity-related hepatocellular carcinoma: insights for chemoprevention of liver cancer
Prof Geoffrey Farrell, 2016-2018, $200,000
Development of broad spectrum, non-genotoxic cancer treatments for acute myeloid leukaemias and multiple myeloma
Principal Investigator
Prof Ross Hannan and A/Prof Anneke Blackburn
Grant Awarded
2015-2018, $340,000
Towards repurposing existing antiretroviral drugs as anticancer agents for cancer therapy
Principal Investigator
Dr Danny Rangasamy, The Australian National University
Grant Awarded
2014-15, $65,000
Novel histone demethylase inhibitors: potential treatment against cancer metastasis and relapse by targeting cancer stem cells
Principal Investigator
A/Prof Sudha Rao, University of Canberra
Grant Awarded
2012-13, $45,164
A new plasmid DNA delivery system - for vaccine development and cancer immunotherapy
Principal Investigator
Dr J Altin, The Australian National University
Grant Awarded
2011-12, $37,000
Chromosome condensation and the regulation of cell development
Principal Investigator
Dr A Fahrer, The Australian National University
Grant Awarded
2010-11, $50,000
Understanding the role of Kleisin beta, a subunit of the condensin II complex, in T cell differentiation
Principal Investigator
Dr A Fahrer, The Australian National University
Grant Awarded
2008-09, $50,000
Dichloroacetate: a novel anti-cancer agent
Principal Investigator
Dr Anneke Blackburn, The Australian National University
Grant Awarded
2009-10, $50,000
Carers of Cancer Patients: Understanding their support service needs.
Principal Investigator
Rebecca Olson, PhD candidate, The Australian National University
Grant Awarded
2007-08, $4,695
Understanding the role of Kleisin beta, a subunit of the condensin II complex, in T cell differentiation.
Principal Investigator
Dr A Fahrer, The Australian National University
Grant Awarded
2006-07, $42,500
Carers of Cancer Patients: A sociological understanding of their emotional and support service experiences
Principal Investigator
Rebecca Olson, PhD candidate, The Australian National University
Grant Awarded
2008-09, $9,390
Cancer clinical trials at The Canberra Hospital
Principal Investigator
Dr D Yip, The Canberra Hospital
Grant Awarded
2007-08, $44,000
A clinical trials cancer research program in the ACT
Principal Investigator
Dr D Yip, Dr P Craft, A/Prof R Stuart-Harris, Dr D Leong, Dr A Davis, The Canberra Hospital
Grant Awarded
2005-06, $33,700
Towards a cancer prevention program for the ACT and SE NSW region. A background paper and mapping exercise.
Principal Investigator
Ms N. Druhan-McGinn
Grant Awarded
2004-06, $31,243
Coping styles and severity of toxicity from adjuvant chemotherapy for early breast cancer
Principal Investigator
A/Prof R Stuart-Harris, The Canberra Hospital and Prof D Byrne, The Australian National University
Grant Awarded
2003-06, $66,000